<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 09, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05618990</url>
  </required_header>
  <id_info>
    <org_study_id>D19-P005</org_study_id>
    <nct_id>NCT05618990</nct_id>
  </id_info>
  <brief_title>OPTIMIZATION of ADVANCED MR SEQUENCES</brief_title>
  <acronym>OPT-IRM</acronym>
  <official_title>OPTIMIZATION of AVANCED MR SEQUENCES for BRAIN STUDIES in VOLUNTEERS (HEALTHY and PATIENTS)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier St Anne</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier St Anne</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This monocentric methodological study aims at optimizing advanced MR sequences for image&#xD;
      quality (reduced artefacts, signal to noise ratio, acquisition time, stability of&#xD;
      quantitative measurements) on a new MR unit dedicated to research in clinical and cognitive&#xD;
      neuroscience.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Primary goal : Optimization of MR protocols and validation of acquisition parameters of&#xD;
      advanced MR sequences on healthy volunteers or patients on a new 3T MR unit dedicated to&#xD;
      research in neurosciences.&#xD;
&#xD;
      Secondary goals&#xD;
&#xD;
        1. Perform acquisitions to validate the feasibility of research MR protocols (pilot&#xD;
           subjects)&#xD;
&#xD;
        2. reproducibility studies&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 5, 2019</start_date>
  <completion_date type="Anticipated">December 5, 2025</completion_date>
  <primary_completion_date type="Anticipated">November 5, 2025</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Other</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>MR sequences optimization</measure>
    <time_frame>72 months</time_frame>
    <description>Optimization of MR protocols and validation of acquisition parameters of advanced MR sequences on healthy volunteers or patients on a new 3T MR unit dedicated to research in neurosciences. Outcome measures depend on each pulse optimized sequence (signal-to-noise ratio, contrast-to-noise ratio, quantitative MR biomarkers).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Reproducibility studies</measure>
    <time_frame>72 months</time_frame>
    <description>Reproducibility studies (quantitative parameters, effect of denoising ...). Outcome measures depend on each pulse optimized sequence (artifacts, signal-to-noise ratio, contrast-to-noise ratio, quantitative MR biomarkers).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pilot studies</measure>
    <time_frame>72 months</time_frame>
    <description>Feasibility studies in cognitive neurosciences. Outcome measures depend on each MR protocol (artifacts, signal-to-noise ratio, contrast-to-noise ratio, quantitative MR biomarkers).</description>
  </secondary_outcome>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Neurosciences</condition>
  <condition>MRI</condition>
  <condition>Brain Tumor</condition>
  <condition>Mental Disorders</condition>
  <condition>Stroke</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Healthy volunteers or patients with brain lesions&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  18 ans&#xD;
&#xD;
          -  Covered by social security&#xD;
&#xD;
          -  For women in age of procreation, under efficient contraception&#xD;
&#xD;
          -  Written consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Any MR contraindication&#xD;
&#xD;
          -  Claustrophobia&#xD;
&#xD;
          -  Pregnancy&#xD;
&#xD;
          -  Under judiciary protection&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Khaoussou SYLLA</last_name>
    <phone>01 45 65 76 78</phone>
    <phone_ext>0033</phone_ext>
    <email>k.sylla@ghu-paris.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Viviane AWASSI</last_name>
    <phone>01 45 65 84 86</phone>
    <phone_ext>0033</phone_ext>
    <email>v.awassi@ghu-paris.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>OPPENHEIM Catherine</name>
      <address>
        <city>Paris</city>
        <zip>75014</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>OPPENHEIM Catherine</last_name>
      <email>C.OPPENHEIM@ghu-paris.fr</email>
    </contact>
    <investigator>
      <last_name>OPPENHEIM Catherine, Doctor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>September 2022</verification_date>
  <study_first_submitted>November 8, 2022</study_first_submitted>
  <study_first_submitted_qc>November 15, 2022</study_first_submitted_qc>
  <study_first_posted type="Actual">November 16, 2022</study_first_posted>
  <last_update_submitted>November 17, 2022</last_update_submitted>
  <last_update_submitted_qc>November 17, 2022</last_update_submitted_qc>
  <last_update_posted type="Actual">November 22, 2022</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Mental Disorders</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

